We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDZI icon
726
Cadiz
CDZI
$259M
– –
-50,409
Closed -$238K
CHWY icon
727
Chewy
CHWY
$9.38B
– –
-5,184
Closed -$210K
CIM
728
Chimera Investment
CIM
$1.06B
– –
-10,332
Closed -$137K
CL icon
729
Colgate-Palmolive
CL
$74.2B
– –
-4,205
Closed -$336K
CLB icon
730
Core Laboratories
CLB
$493M
– –
-17,676
Closed -$218K
CLDT
731
Chatham Lodging
CLDT
$638M
– –
-47,427
Closed -$318K
CLFD icon
732
Clearfield
CLFD
$425M
– –
-7,098
Closed -$244K
CLVT icon
733
Clarivate
CLVT
$1.53B
– –
-11,683
Closed -$44.7K
CM icon
734
Canadian Imperial Bank of Commerce
CM
$109B
– –
-4,678
Closed -$374K
CMCL icon
735
Caledonia Mining Corp
CMCL
$361M
– –
-9,217
Closed -$334K
CMG icon
736
Chipotle Mexican Grill
CMG
$43B
– –
-8,319
Closed -$326K
CNK icon
737
Cinemark Holdings
CNK
$4.09B
– –
-13,837
Closed -$388K
CPF icon
738
Central Pacific Financial
CPF
$1.02B
– –
-9,098
Closed -$276K
CPRX
739
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-12,329
Closed -$243K
CRCT icon
740
Cricut
CRCT
$987M
– –
-16,004
Closed -$101K
CRS icon
741
Carpenter Technology
CRS
$27.8B
– –
-1,303
Closed -$320K
CSGS
742
DELISTED
CSG Systems International
CSGS
– –
-3,324
Closed -$214K
CSV icon
743
Carriage Services
CSV
$648M
– –
-7,208
Closed -$321K
CTGO icon
744
Contango Silver & Gold Inc
CTGO
$529M
– –
-8,327
Closed -$208K
CTS icon
745
CTS Corp
CTS
$1.85B
– –
-6,161
Closed -$246K
CTSH icon
746
Cognizant
CTSH
$23.8B
– –
-4,280
Closed -$287K
CUBI icon
747
Customers Bancorp
CUBI
$2.69B
– –
-3,234
Closed -$211K
CVI icon
748
CVR Energy
CVI
$3.39B
– –
-8,290
Closed -$302K
CWK icon
749
Cushman & Wakefield Ltd
CWK
$3.2B
– –
-12,670
Closed -$202K
CXM icon
750
Sprinklr
CXM
$1.48B
– –
-34,307
Closed -$265K
28 29
30
31 32

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.